Companies: 10,795·Total market cap: $144.5T
ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

ACADNASDAQHealthcare● Active
$21.47
$-0.10(-0.44%)
Market Cap$3.7B
P/E Ratio—
52W High$28.35
52W Low$19.69
Overview

ACADIA Pharmaceuticals Inc. (ACAD) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ACAD · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$819.7M▲ +8.4% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$177.7M
cashAndCashEquivalents
Short-Term Investments
$642.0M
shortTermInvestments
YoY Change vs Prior Year
+8.4%
vs prior fiscal year
Latest Quarter
$851.5M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$819.7MCash on Hand
Total Debt$52.2MTotal Debt
Net Cash / Net Debt+$767.5MNet Cash Position
Cash vs Debt Ratio
Cash 94%Debt 6%

ACADIA Pharmaceuticals Inc. has a net cash position of $767.5M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$819.7M − $52.2M = +$767.5M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ACAD annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$819.7M+8.4%
Dec 31, 2024$756.0M+72.3%
Dec 31, 2023$438.9M+5.3%
Dec 31, 2022$416.8M-20.0%
Dec 31, 2021$520.7M-17.6%
ACAD cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc.YOU
ACAD
$819.7M22.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

ACADIA Pharmaceuticals Inc. (ACAD) cash on hand as of December 31, 2025 is $819.7M, comprising $177.7M in cash and cash equivalents (CCE) plus $642.0M in short-term investments — reported as ACADIA Pharmaceuticals Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as ACADIA Pharmaceuticals Inc. cash reserves or cash position.

ACADIA Pharmaceuticals Inc. annual cash on hand history shows increased +8.4% in 2025: increased +8.4% in 2025. ACADIA Pharmaceuticals Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

ACADIA Pharmaceuticals Inc. carries total debt of $52.2M against cash of $819.7M, resulting in a net cash position of +$767.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ACAD cash on hand · 5 questions

As of December 31, 2025, ACADIA Pharmaceuticals Inc. (ACAD) has $819,686,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $177,695,000 in cash and cash equivalents (CCE) plus $641,991,000 in short-term investments. Latest quarter (March 31, 2026): $851,458,000. Data sourced from the annual 10-K filing via FMP.

ACAD cash on handACAD cash reservesACAD cash 2025how much cash does ACAD have

▸ Source: FMP /balance-sheet-statement · US GAAP · ACADIA Pharmaceuticals Inc. · ACADIA Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025